Ironsides Asset Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-23,961
Closed -$1.93M 89
2017
Q1
$1.93M Sell
23,961
-8,798
-27% -$687K 0.85% 19
2016
Q4
$2.33M Sell
32,759
-1,680
-5% -$132K 0.64% 39
2016
Q3
$2.98M Buy
34,439
+24,121
+234% +$2.1M 0.81% 26
2016
Q2
$895K Sell
10,318
-27,985
-73% -$2.26M 0.27% 65
2016
Q1
$2.87M Buy
38,303
+9,635
+34% +$726K 0.72% 28
2015
Q4
$2.21M Sell
28,668
-4,988
-15% -$375K 0.59% 40
2015
Q3
$2.25M Buy
33,656
+10,906
+48% +$803K 0.63% 32
2015
Q2
$1.69M Buy
+22,750
New +$1.74M 0.48% 47

Other funds holding MDT

Ironsides Asset Advisors's MDT Position: Q2 2017 in Review

Ironsides Asset Advisors sold out of Medtronic (MDT) in Q2 2017, closing a stake of 23,961 shares — an estimated $1.93M sold.

Ironsides Asset Advisors first reported a position in MDT in Q2 2015 and held it in 8 quarters. The position peaked at $2.98M in Q3 2016. 1,281 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

  • Ironsides Asset Advisors reported no remaining Medtronic position as of Q2 2017 after selling out during the quarter.
  • Ironsides Asset Advisors sold 23,961 Medtronic shares in Q2 2017, an estimated $1.93M.
  • Ironsides Asset Advisors first reported a position in Medtronic in Q2 2015 and held it in 8 quarters.
  • Ironsides Asset Advisors's Medtronic position peaked at $2.98M in Q3 2016.
  • 1,281 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on Ironsides Asset Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.